More reads
- Efforts to import drugs from Canada advance at state level, with Florida latest to get in line. (STAT Plus)
- With parting gifts, Gilead CEO's compensation soared. (San Francisco Business Times)
- Karuna Therapeutics raises $68 million to further work on its treatment for schizophrenia. (Boston Globe)
- A Regeneron drug dominates eczema treatment. With new data, a small biotech believes it can compete. (STAT Plus)
No hay comentarios:
Publicar un comentario